Search research articles
Contact Us
Filters
Showing results (51-60 of 138) with videos related to
Page
of 14
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 10, 2009
Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation
Trudy N Small, Andrew D Zelenetz, Ariela Noy, et al.
Haematologica
|
February 29, 2020
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma
Joseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
JCO Global Oncology
|
July 8, 2020
Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study
Robert M Strother, Satish Gopal, Meg Wirth, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 11, 2018
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)
Juan C Ramos, Joseph A Sparano, Michelle A Rudek, et al.
Blood
|
January 24, 2004
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
Tarun Kewalramani, Andrew D Zelenetz, Stephen D Nimer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses
Nicole Lamanna, Joseph G Jurcic, Ariela Noy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047
Alexandra M Levine, Ariela Noy, Jeannette Y Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 2016
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma
Heiko Schöder, Andrew D Zelenetz, Paul Hamlin, et al.
Leukemia & Lymphoma
|
May 31, 2012
Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium
Ulas D Bayraktar, Juan Carlos Ramos, Adam Petrich, et al.
British Journal of Haematology
|
October 16, 2014
Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation
David J Straus, Paul A Hamlin, Matthew J Matasar, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 138) with videos related to
Sort By:
Page
of 14
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 10, 2009
Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation
Trudy N Small, Andrew D Zelenetz, Ariela Noy, et al.
Haematologica
|
February 29, 2020
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma
Joseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
JCO Global Oncology
|
July 8, 2020
Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study
Robert M Strother, Satish Gopal, Meg Wirth, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 11, 2018
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)
Juan C Ramos, Joseph A Sparano, Michelle A Rudek, et al.
Blood
|
January 24, 2004
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
Tarun Kewalramani, Andrew D Zelenetz, Stephen D Nimer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses
Nicole Lamanna, Joseph G Jurcic, Ariela Noy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047
Alexandra M Levine, Ariela Noy, Jeannette Y Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 2016
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma
Heiko Schöder, Andrew D Zelenetz, Paul Hamlin, et al.
Leukemia & Lymphoma
|
May 31, 2012
Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium
Ulas D Bayraktar, Juan Carlos Ramos, Adam Petrich, et al.
British Journal of Haematology
|
October 16, 2014
Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation
David J Straus, Paul A Hamlin, Matthew J Matasar, et al.
Page
of 14